|
FOXN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.47324424565932E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.00217661631086E-13 |
| Normal-vs-Stage2 |
6.846300E-04 |
| Normal-vs-Stage3 |
3.33299998711567E-09 |
| Normal-vs-Stage4 |
4.480000E-03 |
| Stage1-vs-Stage2 |
4.259200E-01 |
| Stage1-vs-Stage3 |
8.446800E-01 |
| Stage1-vs-Stage4 |
4.805200E-01 |
| Stage2-vs-Stage3 |
3.963600E-01 |
| Stage2-vs-Stage4 |
3.431400E-01 |
| Stage3-vs-Stage4 |
6.557800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.78332912273527E-12 |
| Normal-vs-AfricanAmerican |
9.743900020176E-09 |
| Normal-vs-Asian |
3.79190000000529E-05 |
| Caucasian-vs-AfricanAmerican |
8.908400E-01 |
| Caucasian-vs-Asian |
6.139000E-01 |
| AfricanAmerican-vs-Asian |
5.830000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.29443155983245E-12 |
| Normal-vs-Female |
4.62820000102226E-08 |
| Male-vs-Female |
5.601800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.17739999971889E-07 |
| Normal-vs-Extreme_Weight |
8.58920046198364E-10 |
| Normal-vs-Obese |
3.66169999876931E-08 |
| Normal-vs-Extreme_Obese |
1.66764999999236E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.294600E-01 |
| Normal_Weight-vs-Obese |
6.073000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.435200E-01 |
| Extreme_Weight-vs-Obese |
5.108600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.947400E-01 |
| Obese-vs-Extreme_Obese |
6.048800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.86689999962064E-07 |
| Normal-vs-Age(41-60Yrs) |
9.58069956702445E-10 |
| Normal-vs-Age(61-80Yrs) |
3.53606033343112E-12 |
| Normal-vs-Age(81-100Yrs) |
2.36880000004103E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.913000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.999200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.815200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.544990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.256600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.919600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.98829841480119E-12 |
| Normal-VS-Type2 PRCC |
9.1207996710807E-10 |
| Normal-VS-KIRP CIMP |
1.68130000033351E-07 |
| Normal-VS-Unclassified PRCC |
3.722800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.629000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.866400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.050300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.127800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.284230E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.028770E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.04469790993289E-11 |
| Normal-vs-N1 |
1.586269999998E-05 |
| Normal-vs-N2 |
2.20629999999611E-05 |
| N0-vs-N1 |
6.048800E-01 |
| N0-vs-N2 |
5.497600E-01 |
| N1-vs-N2 |
4.717000E-01 |
|
|
